Cynthia L. Goldenberg

Cynthia L. Goldenberg has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Immunomedics Inc and Digene Corp. In total, 101 filings cover trades dated from 27 February 2006 to 1 September 2017.

In open-market terms, that means 7 purchases worth €230k on one side and 30 sales worth €5.5M on the other. The net balance comes to €5.2M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 31 share grants and 30 option exercises. In 2017 alone, the filings show no purchases and 9 sales.

A typical purchase (the median) is worth €5,465.

The latest filing, published on 5 September 2017, reports an open-market sale of €108k in Immunomedics Inc. The last insider purchase was made public on 6 March 2009, 6,441 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.